Bionic Vision advances clinical programme with Australian government grant
Melbourne-based Australian medical technology start-up Bionic Vision Technologies (BVT) has announced that it is advancing next phase of development for…
Latest Medical Devices
-
2 weeks
-
3 weeks
-
5 months
-
1 year
-
2 weeks
-
3 weeks
-
5 months
-
1 year
InSilicoTrials: accelerating the uptake of simulation in clinical research
A new EU-funded project, In Silico World, is aiming to encourage the use of simulation in the development of drugs…
Latest News
View More
Industry Viewpoints: A Sea of Change in the Medical Device Landscape
With the Medical Device Regulation (MDR) starting make its presence felt within the industry, device companies, large and small, have been making process adjustments, ensuring…
Announcing ‘Medical Device Week’ on Clinical Trials Arena
The time has come – Medical Device Week has returned to CTA! Back by popular demand, CTA’s August spotlight seeks to answer all the burning…
The Top 5: June 2018
There were numerous articles in June 2018 that covered a wide range of topical issues. Here are five of the…
The Top 5: March 2018
There were numerous articles in March 2018 that covered a wide range of topical issues. Here are five of the…
The Top 5: January 2018
There were numerous articles in January 2018 that covered a wide range of topical issues. For one, January featured a…
How to Effectively Manage CROs
I’ve generally had very strong relationships with contract research organizations (CROs), but when I started to write this article, it…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View More
WHO Report Highlights Need for Global Antimicrobial Stewardship
On Nov. 12, the World Health Organization (WHO) kicked off World Antibiotic Awareness Week by publishing its first report on…
12-Lead ECG Systems in Clinical Trials
Cardiac toxicity is one of the primary reasons pharmaceutical products were withdrawn from the market in the past. The International…
COSELA™ (trilaciclib) for the Treatment of Chemotherapy-Induced Myelosuppression, US
COSELA™ (trilaciclib) is the first approved myeloprotection therapy indicated to reduce the occurrence of chemotherapy-induced bone marrow suppression in adult…
UKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…